Marc has been President and Chief Executive Officer of Thermo Fisher Scientific since October 2009. He joined the company in 2001 as President of the Life Sciences sector of Thermo Electron. He was named Senior Vice President in 2003, and in 2005 was given responsibility for all of the company’s operating divisions. After the merger creating Thermo Fisher Scientific in 2006, Marc was named President of Analytical Technologies, and in 2008 was named Chief Operating Officer.
Prior to joining Thermo Fisher, Marc served as President, Chief Executive Officer and a director of Kendro Laboratory Products. Before Kendro, he worked for clinical diagnostics provider Dade Behring Inc., where he served as President – Americas. Marc began his career at Bain Company as a strategy consultant and later joined Bain Capital.
Marc received an MBA with high distinction from Harvard Business School and is a graduate of Wesleyan University, where he received a bachelor’s degree in economics. Marc serves on the Brigham Women’s Hospital Board of Trustees, US-China Business Council and the Massachusetts Math Science Initiative. He is also a member of the Business Roundtable, an association of CEOs of leading U.S. companies. He was previously a director of the Advisory Board Company and Zimmer Holdings.
Thermo Fisher Scientific is an American multinational, biotechnology product development company, created in 2006 by the merger of Thermo Electron and Fisher Scientific.[1][2] In April 2013, after a competitive bidding with Hoffmann-La Roche,[3] Thermo Fisher acquired Life Technologies Corp for $13.6 billion in a deal that would rank the firm as one of the leading companies in the genetic testing and precision laboratory equipment markets.[4][5][6]
